Lisa Raedler, PhD | Authors

Articles

Tumor Antigens and Their Role in Immune Response in Melanoma

March 24, 2015

Melanoma is the most deadly skin cancer. According to data collected between 2004 and 2010, only 16% of Americans with metastatic melanoma, including people of all ages and races, and both genders, survive for 5 years or more after diagnosis.